Andrew Weaver

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

Harpreet Wasan, Navesh Sharma, Volker Heinemann et al. · The Lancet Oncology · 2017 · 398 citations · Full text

Medicine, Oncology, Radiation Oncology +17

3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial

Timothy Iveson, Rachel Kerr, Mark Saunders et al. · The Lancet Oncology · 2018 · 188 citations · Full text

Medicine, Oncology, Pharmacology +16

Application of mobile phone technology for managing chemotherapy-associated side-effects

Andrew Weaver, Annie Young, Joanna Rowntree et al. · Annals of Oncology · 2007 · 158 citations

Nursing, Health Informatics, Oncology +14

Peptide receptor radionuclide therapy in gastroenteropancreatic NEN G3: a multicenter cohort study

Esben Andreas Carlsen, Nicola Fazio, Simona Grozinsky‐Glasberg et al. · Endocrine Related Cancer · 2018 · 158 citations · Full text

Medicine, Nuclear Medicine, Oncology +16

An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1/Th2 polarization

Andrew Weaver, Angelika Goncalves Da Silva, Robert K. Nuttall et al. · The FASEB Journal · 2005 · 157 citations

Life Sciences, Immunology, Neuroscience +17